In addition, YQSX may exert its regulatory function in the pathogenesis of ITP and the regulation of pathways including proteoglycans in cancer, prostate cancer, glioma, and thyroid hormone and estrogen signaling pathways which are associated with the occurrence of ITP. This evidence concerns the gene TG and autoimmune thrombocytopenic purpura.